Kwang Dong Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kwang Dong Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Hanmi Pharmaceutical., Company Limited
sales of 916.59 billion Korean Won [US$808.43 million]
of which 76%
Daewoong Company Limited
(1.12 trillion Korean Won [US$991.43 million]
of which 113%
was Medicinal Manufacturing & Selling), and
Daewoong Pharmaceutical Company Limited
(960.31 billion Korean Won [US$846.99 million]
of which 101%
was Medicine Manufacture&Sale).
During the year ended December of 2017, sales at
Kwang Dong Pharmaceutical Company Limited were 1.14 trillion Korean Won (US$1.01 billion).
increase of 8.1%
versus 2016, when the company's sales were 1.06 trillion Korean Won.
This was the fifth consecutive year of sales increases at Kwang Dong Pharmaceutical Company Limited
(and since 2012, sales have increased a total of 243%).
Sales of Other Segements saw an increase
that was more than double the company's growth rate: sales were up
59.5% in 2017, from
13.60 billion Korean Won to 21.70 billion Korean Won.
Kwang Dong Pharmaceutical Company Limited also saw significant increases in sales in
Pharmacy Operations (up 13.0% to 226.83 billion Korean Won)